New partners team up for Phase 2 trial of novel lithium therapy AL001
Alzamend Neuro is partnering with Mass General Hospital for a Phase 2 trial of AL001, a next-generation lithium drug for Alzheimer’s dementia.
0 Comments
New partners team up for Phase 2 trial of novel lithium therapy AL001
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed